Testing for mismatch repair (MMR) and microsatellite instability (MSI) among patients with colorectal cancer (CRC) increased from 22.7% in 2012 to 71.5% in 2021, but variations in access remain, with ...
Dr Philippe Taniere – Understanding biomarker testing for immunotherapy; PD-L1 (Programmed Death-Ligand 1) expression, Mismatch Repair (MMR) testing and the importance of Microsatellite Instability ...
NORTHFIELD, Ill.--(BUSINESS WIRE)--Recognizing a need for evidence-based recommendations to guide molecular testing in the management of patients with cancer, the College of American Pathologists (CAP ...
MSI by NGS allowed for simultaneous screening for LS and categorization of EC into molecular subtypes with prognostic and therapeutic implications. NGS readily identified the four EC molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback